Cutaneous vasculitis in autoinflammatory diseases
The Journal of Dermatology · 2024-02 · 51 (2) · 150-159
DOI: 10.1111/1346-8138.17030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, online erschienen am 13.11.2023. Verfasst von Ko-Ron Chen. Beteiligte Einrichtung: Meguro Chen Dermatology Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Livedo Reticularis, Vasculitis, Polyarteritis Nodosa, Skin Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoinflammatory diseases (AIDs) characterized by recurrent episodes of localized or systemic inflammation are disorders of the innate immune system. Skin lesions are commonly found in AIDs and cutaneous vasculitis can coexist with AIDs and even present as the most striking feature. This review aims to focus on the frequent cutaneous vasculitis association in three monogenic AIDs including familial Mediterranean fever (FMF), deficiency of adenosine deaminase type 2 (DADA2), and the recently identified adult‐onset VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Cutaneous vasculitis in FMF is characterized by: (1) small‐vessel vasculitis similar to IgA vasculitis with palpable purpura but increased intussusception complication and less vascular IgA deposit, and (2) cutaneous arteritis–like vasculitis presenting as subcutaneous nodules most often with higher glomerular involvement. DADA2 has a wide spectrum of clinical presentations ranging from fatal systemic vasculitis with multiple strokes, especially in pediatric patients, to limited cutaneous disease in middle‐aged patients. DADA2 shares similar clinical and histopathological features with polyarteritis nodosa (PAN). As a result, DADA2 is commonly initially misdiagnosed as childhood PAN. Livedo racemosa reveals the most common cutaneous manifestation of cutaneous vasculitis in patients with DADA2. VEXAS syndrome is a life‐threatening disease. A diagnosis of VEXAS syndrome should be strongly considered or could be made in patients with skin lesions characterized by Sweet syndrome–like eruption, livedo racemosa, concomitant relapsing polychondritis, deep venous thrombosis, pulmonary involvement, and progressive hematologic abnormalities such as myelodysplastic syndrome with a unique finding of cytoplasmic vacuoles in myeloid and erythroid precursor cells from bone marrow aspirate smear. As skin involvement is common in AIDs and may present as the most frequent manifestation, especially in DADA2 (70% to 90%) and VEXAS syndrome (83% to 91%), dermatologists play a crucial role in contributing to the early diagnosis of these AIDs with early initiation of the appropriate therapy to avoid progressing fatal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meguro Chen Dermatology Clinic, Tokyo, Japan.
Zitieren
APA
Chen, K. R. (2024). Cutaneous vasculitis in autoinflammatory diseases. The Journal of Dermatology, 51(2), 150-159. https://doi.org/10.1111/1346-8138.17030
Vancouver
Chen KR. Cutaneous vasculitis in autoinflammatory diseases. The Journal of Dermatology. 2024;51(2):150-159. doi:10.1111/1346-8138.17030
BibTeX
@article{Chen2024,
author = {Chen, Ko-Ron},
title = {Cutaneous vasculitis in autoinflammatory diseases},
journal = {The Journal of Dermatology},
year = {2024},
volume = {51},
number = {2},
pages = {150--159},
doi = {10.1111/1346-8138.17030}
}
EUVIMED